Differential changes in induced seizures after hippocampal treatment of rats with an antisense oligodeoxynucleotide to the GABA(A) receptor gamma2 subunit

European Journal of Pharmacology
J KarleM Nielsen

Abstract

Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the brain. Impairment of GABAergic neurotransmission may be involved in the pathogenesis of epileptic phenomena. We have previously characterized biochemical and histological changes following unilateral intrahippocampal infusion of a phosphorothioate antisense oligodeoxynucleotide to the GABA(A) receptor gamma2 subunit in rats in vivo. The aim of the present study was to investigate the behavioral changes of rats following unilateral hippocampal antisense 'knockdown' of the GABA(A) receptor gamma2 subunit. Antisense, but not mismatch control oligodeoxynucleotide treated rats had a significant weight loss (10%) during 6 d of treatment. Antisense treated rats exhibited no changes in spontaneous behavior, including anxiety-like behavior as measured in the social interaction test, compared to mismatch oligodeoxynucleotide treated rats. However, antisense treated rats developed pronounced changes in induced seizure activity. Seizures induced by subcutaneously injected pentylenetetrazol were markedly accentuated in antisense treated rats compared to treatment naive rats, whereas mismatch treated rats showed a lower seizure score than that of naive rats. A...Continue Reading

References

Aug 1, 1978·European Journal of Pharmacology·R SchwarczJ T Coyle
Jan 1, 1989·British Journal of Clinical Pharmacology·B S Meldrum
Nov 1, 1987·Annals of Neurology·J W MillerJ A Ferrendelli
Jan 1, 1994·Progress in Neurobiology·G Sperk
Jan 1, 1994·Annual Review of Neuroscience·R L Macdonald, R W Olsen
Feb 1, 1994·Trends in Pharmacological Sciences·C Wahlestedt
Oct 1, 1993·Brain Pathology·S M Thompson
Dec 1, 1989·Journal of Neurosurgical Anesthesiology·F F Johansen, M M O'Hare

❮ Previous
Next ❯

Citations

Apr 2, 1999·Brain Research. Molecular Brain Research·W Mu, D R Burt
Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Alon ShamirGalila Agam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.